169 related articles for article (PubMed ID: 28797691)
1. Antidepressant-like activity of venlafaxine and clonidine in mice exposed to single prolonged stress - A model of post-traumatic stress disorder. Pharmacodynamic and molecular docking studies.
Malikowska N; Fijałkowski Ł; Nowaczyk A; Popik P; Sałat K
Brain Res; 2017 Oct; 1673():1-10. PubMed ID: 28797691
[TBL] [Abstract][Full Text] [Related]
2. Exploring a post-traumatic stress disorder paradigm in Flinders sensitive line rats to model treatment-resistant depression II: response to antidepressant augmentation strategies.
Brand SJ; Harvey BH
Acta Neuropsychiatr; 2017 Aug; 29(4):207-221. PubMed ID: 27692010
[TBL] [Abstract][Full Text] [Related]
3. D-578, an orally active triple monoamine reuptake inhibitor, displays antidepressant and anti-PTSD like effects in rats.
Dutta AK; Santra S; Harutyunyan A; Das B; Lisieski MJ; Xu L; Antonio T; Reith MEA; Perrine SA
Eur J Pharmacol; 2019 Nov; 862():172632. PubMed ID: 31473161
[TBL] [Abstract][Full Text] [Related]
4. Dopamine D2/D3 receptor agonists attenuate PTSD-like symptoms in mice exposed to single prolonged stress.
Malikowska-Racia N; Sałat K; Nowaczyk A; Fijałkowski Ł; Popik P
Neuropharmacology; 2019 Sep; 155():1-9. PubMed ID: 31085186
[TBL] [Abstract][Full Text] [Related]
5. Structure-activity relationships of bath salt components: substituted cathinones and benzofurans at biogenic amine transporters.
Eshleman AJ; Nagarajan S; Wolfrum KM; Reed JF; Swanson TL; Nilsen A; Janowsky A
Psychopharmacology (Berl); 2019 Mar; 236(3):939-952. PubMed ID: 30397775
[TBL] [Abstract][Full Text] [Related]
6. Computational identification of the binding mechanism of a triple reuptake inhibitor amitifadine for the treatment of major depressive disorder.
Xue W; Wang P; Tu G; Yang F; Zheng G; Li X; Li X; Chen Y; Yao X; Zhu F
Phys Chem Chem Phys; 2018 Feb; 20(9):6606-6616. PubMed ID: 29451287
[TBL] [Abstract][Full Text] [Related]
7. Activation of indoleamine 2, 3- dioxygenase pathway by olanzapine augments antidepressant effects of venlafaxine in mice.
Thomas J; Khanam R; Vohora D
Psychiatry Res; 2017 Dec; 258():444-448. PubMed ID: 28911850
[TBL] [Abstract][Full Text] [Related]
8. Extended-release formulation of venlafaxine in the treatment of post-traumatic stress disorder.
Pae CU; Lim HK; Ajwani N; Lee C; Patkar AA
Expert Rev Neurother; 2007 Jun; 7(6):603-15. PubMed ID: 17563244
[TBL] [Abstract][Full Text] [Related]
9. [Posttraumatic stress disorder (PTSD) as a consequence of the interaction between an individual genetic susceptibility, a traumatogenic event and a social context].
Auxéméry Y
Encephale; 2012 Oct; 38(5):373-80. PubMed ID: 23062450
[TBL] [Abstract][Full Text] [Related]
10. Modulation of muscarinic system with serotonin-norepinephrine reuptake inhibitor antidepressant attenuates depression in mice.
Singh P; Singh TG
Indian J Pharmacol; 2015; 47(4):388-93. PubMed ID: 26288470
[TBL] [Abstract][Full Text] [Related]
11. Risperidone ameliorates post-traumatic stress disorder-like symptoms in modified stress re-stress model.
Krishnamurthy S; Garabadu D; Joy KP
Neuropharmacology; 2013 Dec; 75():62-77. PubMed ID: 23891637
[TBL] [Abstract][Full Text] [Related]
12. Binding of the amphetamine-like 1-phenyl-piperazine to monoamine transporters.
Severinsen K; Kraft JF; Koldsø H; Vinberg KA; Rothman RB; Partilla JS; Wiborg O; Blough B; Schiøtt B; Sinning S
ACS Chem Neurosci; 2012 Sep; 3(9):693-705. PubMed ID: 23019496
[TBL] [Abstract][Full Text] [Related]
13. Differential effectiveness of tianeptine, clonidine and amitriptyline in blocking traumatic memory expression, anxiety and hypertension in an animal model of PTSD.
Zoladz PR; Fleshner M; Diamond DM
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jul; 44():1-16. PubMed ID: 23318688
[TBL] [Abstract][Full Text] [Related]
14. Focus on Human Monoamine Transporter Selectivity. New Human DAT and NET Models, Experimental Validation, and SERT Affinity Exploration.
Ortore G; Orlandini E; Betti L; Giannaccini G; Mazzoni MR; Camodeca C; Nencetti S
ACS Chem Neurosci; 2020 Oct; 11(20):3214-3232. PubMed ID: 32991141
[TBL] [Abstract][Full Text] [Related]
15. Comparative modeling of the human monoamine transporters: similarities in substrate binding.
Koldsø H; Christiansen AB; Sinning S; Schiøtt B
ACS Chem Neurosci; 2013 Feb; 4(2):295-309. PubMed ID: 23421681
[TBL] [Abstract][Full Text] [Related]
16. Interaction of antidepressants with the serotonin and norepinephrine transporters: mutational studies of the S1 substrate binding pocket.
Sørensen L; Andersen J; Thomsen M; Hansen SM; Zhao X; Sandelin A; Strømgaard K; Kristensen AS
J Biol Chem; 2012 Dec; 287(52):43694-707. PubMed ID: 23086945
[TBL] [Abstract][Full Text] [Related]
17. Selective dopamine D
Rice OV; Ashby CR; Dixon C; Laurenzo W; Hayden J; Song R; Li J; Tiwari AK; Gardner EL
Synapse; 2018 Aug; 72(8):e22035. PubMed ID: 29704283
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugs.
Han DD; Gu HH
BMC Pharmacol; 2006 Mar; 6():6. PubMed ID: 16515684
[TBL] [Abstract][Full Text] [Related]
19. Repeated administration of AC-5216, a ligand for the 18 kDa translocator protein, improves behavioral deficits in a mouse model of post-traumatic stress disorder.
Qiu ZK; Zhang LM; Zhao N; Chen HX; Zhang YZ; Liu YQ; Mi TY; Zhou WW; Li Y; Yang RF; Xu JP; Li YF
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():40-6. PubMed ID: 23624119
[TBL] [Abstract][Full Text] [Related]
20. Monoamine transporter contributions to l-DOPA effects in hemi-parkinsonian rats.
Conti MM; Meadows SM; Melikhov-Sosin M; Lindenbach D; Hallmark J; Werner DF; Bishop C
Neuropharmacology; 2016 Nov; 110(Pt A):125-134. PubMed ID: 27452719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
